Jazz Pharmaceuticals Director Bruce C. Cozadd Sells 6,000 Shares

What Happened
Bruce C. Cozadd, a director of Jazz Pharmaceuticals (JAZZ), sold 6,000 shares on August 3, 2026 at $252.98 per share, generating proceeds of $1,517,880. The filing classifies the transaction as a sale and indicates it was executed under a pre-established plan.

Key Details

• Transaction date: 2026-08-03
• Amount sold: 6,000 shares at $252.98 per share; total proceeds $1,517,880
• Method: Sale (S) — reported as open-market/private sale; executed under a 10b5-1 plan
• Footnote: The trade was made pursuant to a 10b5-1 plan adopted by the reporting person on November 26, 2025; it occurred automatically and was not a discretionary transaction by the reporting person (Footnote F1)
• Shares owned after transaction: not specified in this filing
• Filing timeliness: Filed Aug 5, 2026 for an Aug 3 transaction (appears timely)

Context
Sales under 10b5-1 plans are pre-scheduled and typically reflect automated or routine dispositions rather than contemporaneous insider views. This report is informational for investors tracking insider activity but does not by itself indicate the director’s current view on the company’s prospects.